Ultra HTS Picks Up Momentum

FRAMINGHAM (10/23/2003) - BioTrove Inc. has put its second integrated platform release, Momentum, to work in a patented ultra-high-throughput mass spectrometry service enabling microliter-scale functional assay development and screening of intractable targets. Through the Momentum Screening Service, BioTrove collaborates with customers to develop label-free assays and to screen chemical libraries against biological targets.

Momentum features a maximum sustainable throughput of one sample per second. With Momentum, an assay can be developed and validated for a novel target and screened against a small-molecule library in less than one month, BioTrove says.

Copyright 2017 IDG Communications. ABN 14 001 592 650. All rights reserved. Reproduction in whole or in part in any form or medium without express written permission of IDG Communications is prohibited.